Global Thrombectomy Devices Market Size study & Forecast, by Type (Ultrasound, Aspiration, Mechanical Thrombectomy, Others), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) and Re

Global Thrombectomy Devices Market Size study & Forecast, by Type (Ultrasound, Aspiration, Mechanical Thrombectomy, Others), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) and Regional Analysis, 2022-2029

Global Thrombectomy Devices Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Thrombectomy devices have high-resolution video recordings, better image features, and a nice texture. It has major advantages in entertainment, consumer electronics, digital cinema, and other fields. The market for Thrombectomy Devices is growing because of factors such as rising incidences of cardiovascular diseases and growing adoption of minimally invasive procedures.

According to the World Health Organization (WHO), around 17 million deaths take place with the rising prevalence of the cardiovascular disease across the globe. And around 31% of death across the world are expected due to heart-related problems. Patients suffering from such chronic cardiac conditions develop clotting which increases the risk of sudden heart failure. Whereas as rising number of hospitals and surgical centers and the growing geriatric population across the globe create lucrative opportunities for the market. However, a lack of awareness regarding peripheral artery diseases hampers the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Thrombectomy Devices Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing incidences of neurological disorders, rising approval of thrombectomy devices, growing surgical procedures, and so on. Whereas Asia Pacific is deemed as the fastest growing region in terms of highest CAGR owing to the growing geriatric population, rising government insurance coverage in developing economies in the forecast period.

Major market players included in this report are:
Medtronic plc (Ireland),
Abbott Laboratories
Boston Scientific Corporation (U.S.),
Johnson & Johnson Services, Inc.
Terumo Corporation (Japan),
Penumbra, Inc. (U.S.),
Spectranetics Corporation (U.S.),
Edwards Lifesciences Corporation (U.S.),
Argon Medical Devices, Inc. (U.S.),
Teleflex Incorporated (U.S.),

Recent Developments in the Market:
 In September 2021, Devoro Medical, Inc., with its WOLF thrombectomy platform, was acquired by Boston Scientific Corporation. This platform uses finger-like prongs combined with lytic-free WOLF technology to target and detain blood clots. This will expand the company's product portfolio in the market for thrombectomy devices.
 In September 2020, CERENOVUS, a division of Johnson & Johnson, introduced the CERENOVUS Stroke Solutions suit, which includes the CERENOVUS large-bore catheter, the EMBOTRAP III revascularization device, and the CEREBASE DA guide sheath for blood clot management. This has broadened the company's product offerings in the important market, boosting segment revenue growth.
Global Thrombectomy Devices Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Application, End-user, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the market’s future growth. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:
By Type:
By Application:
Cardiovascular Application
Peripheral Vascular Application
Neurovascular Application

By End-user:

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Companies Mentioned

Medtronic plc (Ireland),
Abbott Laboratories
Boston Scientific Corporation (U.S.),
Johnson & Johnson Services, Inc.
Terumo Corporation (Japan),
Penumbra, Inc. (U.S.),
Spectranetics Corporation (U.S.),
Edwards Lifesciences Corporation (U.S.),
Argon Medical Devices, Inc. (U.S.),
Teleflex Incorporated (U.S.),

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.